This is part two of a two-part article offering proposals to improve the FDA’s draft guidance to implement a new approval ...
The DoJ intervened in the whistleblower lawsuit, alleging that the MA Organizations paid the broker defendants hundreds of ...
This is part one of a two-part article offering proposals to improve the FDA’s guidance to implement a new approval framework ...
Ultra-rare diseases often lack patient populations large enough to support randomized controlled trials. The question is not ...
CMS and states can take practical, near-term policy actions to strengthen whole-person care for dual-eligible beneficiaries ...
Nearly two decades ago, Congress passed the US Food and Drug Administration (FDA) Amendments Act of 2007 , partially in ...
The Camden Coalition’s Community Ecosystem Alignment Tool can help diagnose coordination gaps, improve performance, and ...
Stakeholders have expressed longstanding concerns with how the Centers for Medicare and Medicaid Services (CMS) has ...
HIPAA was not designed to protect patients in a world where their medical samples can be repurposed as a full forensic ...
CMS rulemaking or Congress should remove the outdated coverage exclusion on obesity treatment for Medicare beneficiaries.
The delayed implementation of the model in Medicare gives CMS, plans, and manufacturers an opportunity to address key ...
Can the model generate sufficient clinical improvement to justify the likely distortions that accompany large-scale payment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results